A Study to Form a Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)


About this study

The purpose of this study is to form a registry to follow patients with sarcoidosis associated pulmonary hypertension

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria

  • Sarcoidosis as defined by the ATS/WASOG statement
  • Pulmonary hypertension as confirmed by right heart catheterization
  • Provide written informed consent

Exclusion Criteria

  • Unwillingness to provide assurance that they will complete the follow up visits for the study

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eva Carmona Porquera, M.D., Ph.D.

Open for enrollment

Contact information:

Pulmonary Clinical Research Unit

(800) 753-1606


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available